|
AIDS
Online Submission and Review System
|
|
Instructions for Authors on the Preparation and Submission of Manuscripts to AIDS
Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the "Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals" at www.icmje.org.
The Journal is a member of the Committee on Publication Ethics (COPE) which aims to define best practice in the ethics of scientific publishing. COPE has established a number of guidelines as part of a set of Core Practices (www.publicationethics.org).
Appeals on editorial decisions should be sent to the Editor. Complaints related to how your paper was processed during peer-review and not resolved by the Editor, should be referred to the person named as publisher in "About the Journal" under "Journal Info" contacts (http://journals.lww.com/aidsonline/) or if unsatisfied to COPE (www.publicationethics.org).
This Journal allows authors to choose an Open Access option for their published article on payment of a fee. See the Open Access section below.
SCOPE
The latest ground-breaking research and notable observations in HIV and AIDS are presented in AIDS. The Journal publishes high-quality papers reporting original scientific, clinical, epidemiological, and social research. We especially welcome contributions on basic science, community-based research, implementation studies, and clinical trials that contribute to the overall knowledge of the field. The selected articles include Original Papers, Concise Communications, Field Notes, Research Letters, and Correspondence, as well as invited Editorial Reviews, Opinion Pieces, Viewpoints, Editorial Comments, and Fast Track articles. Fast Track is designed for publication, in the fastest time possible, of original short papers that contain important and time-sensitive information.
All manuscript submissions to the regular issues and supplements of the Journal are peer-reviewed. Submitted articles have a preliminary evaluation by the editors, and those considered for publication undergo further assessment by the editors and selected reviewers. The Journal uses a single-blind process for peer-review. Papers may be subject to a statistical analysis. Short comments can be considered as Correspondence: case reports are not encouraged.
SUBMISSIONS
Authors should submit their manuscripts through the web-based tracking system at http://aids.edmgr.com/. The site contains instructions and advice on how to use the system. Authors should NOT in addition then post a hard copy submission to the editorial office.
Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate sheet: Title Page, abstract (when required) and keywords, text, acknowledgements, references, individual tables and captions. Margins should be at least 3 cm. Pages should be numbered consecutively, beginning with the Title Page, and the page number should be placed in the top right-hand corner of each page. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided. The word count should be clearly stated on the Title Page.
Authors are invited to list up to six potential reviewers, including their full addresses, telephone and fax numbers, and e-mail addresses.
A Fast Track option is available for papers that contain time-sensitive and important information.
Person-centered language: Consider carefully how individuals or groups of individuals are described in a paper. Avoid defining people by their health condition or treatment or a term that stigmatises or dehumanises. For example, instead of HIV-infected people, use people with HIV.
Non-native speakers of English: Authors who are not native speakers of English and require help in writing an article in English are encouraged to seek assistance from a qualified colleague or consider using a language service in preparing a manuscript submission. Wolters Kluwer, in partnership with Editage, offers such services - for more information please visit http://wkauthorservices.editage.com. Please note that the use of this or other services are at the author's own expense and risk, and independent from the editorial processes of this journal, and does not guarantee that an article will be accepted for publication.
Article Types
|
Fast Track |
Original Papers
Manuscripts should be concise and not be more than 3500 words, with up to
five figures or tables. Papers will be returned if they exceed the maximum
stated. The word limit refers to the main body of the text and does not
include the abstract, references or figure legends.
Concise Communications
Original research findings that do not require a full paper, but are completed
studies, may be submitted as Concise Communications. Papers should not exceed
1800 words, and may be accompanied by a maximum of two inserts only (figures/tables).
Papers submitted for consideration as Concise Communications should be clearly
identified in the authors covering letter.
Research Letters
Research Letters provide a forum for original research results, excluding
case reports, and observations that merit publication and can be reported
succinctly. Research letters are reviewed by the Editors or external
reviewers. Research letters should include a summary of up to 75 words,
not exceed 1000 words (excluding summary) and not have more than one
figure or
table.
Correspondence
The correspondence section is reserved for case reports, and letters that
are addressing issues or exchanging views on topics arising from published
articles in the journal. Correspondence should not exceed 750 words and
not have more than one figure or table. These letters are subject
to review by the Editors, and may be rejected without written explanation.
In some instances, correspondence will be peer-reviewed.
Editorial Reviews
AIDS features reviews on various topics in HIV/AIDS. These articles are invited by the editors. Individuals can write to the editors to ask about an interest in a review. If approved, they will be then officially invited to write one. The instructions are subsequently provided by the Editorial office.
Opinion Piece and Viewpoint
The Journal will consider articles that review in detail the literature on a topic and give an opinion of an author (s) on that particular area of HIV/AIDS. The Opinion Pieces should be limited to 2500 words and can have up to four illustrations or tables.
A Viewpoint is a brief description of an issue in HIV/AIDS and the opinion of the author (s) on that issue. Viewpoints are limited to 1500 words and can have one figure or table.
The papers will be subject to the same review process as other original articles. Opinion Pieces and Viewpoint articles should NOT include an abstract.
Field Notes
Articles describing experiences with diagnosing and treating HIV infection and its accompanying opportunistic infections and cancers will be considered for this section of the journal. These contributors should report personal experiences and give insight into the way culture and medical care within a particular part of the world influences the approaches taken for HIV/AIDS. Preference is given to individuals working in developing countries. The length should be no longer than 1500 words and can have up to 4 illustrations. Field Notes articles should NOT include an abstract. Please indicate this section when submitting the manuscript.
According to AIDS Editorial policy, the Editors will not enter into direct correspondence regarding a submission to the journal. Where clarification about a decision is requested, all communications should be made in writing and directed to the Editorial Office ([email protected]). The Journal is a member of the Committee on Publication Ethics (COPE) which aims to define best practice in the ethics of scientific publishing. COPE has established a number of guidelines as part of a set of Core Practices (www.publicationethics.org).
Appeals on editorial decisions should be sent to the Editorial Office. Complaints related to how your paper was processed during peer-review and not resolved by the Editor through the Editorial Office, should be referred to the person named as publisher in "Journal Info" contacts (http://journals.lww.com/aidsonline/Pages/aboutthejournal.aspx), or if unsatisfied to COPE (www.publicationethics.org).
POINTS TO CONSIDER BEFORE SUBMISSION
Redundant or duplicate publication
Submissions are accepted on the understanding that they have not been published in their current form or a substantially similar form (in print or electronically, including on a web site), that they have not been accepted for publication elsewhere, and they are not under consideration by another publication. If you are in doubt (particularly in the case of material that you have posted on a web site or an abstract of your work), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals.
Preprints: Work posted on a preprint server, which identifies a preprint as not peer-reviewed, will be considered for publication. The author should declare preprint server deposition on submitting their article to the Journal. If the article is accepted, to ensure readers can find and cite the final published version, authors should add the Digital Object Identifier (DOI) of the published journal article to the posted preprint version.
Conflicts of interest
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:". For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speakers bureau for Organization X the CME organizers for Company A. For the remaining authors none were declared.
Each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors(www.icmje.org/update.html). The copyright agreement is included in the Author Questionnaire, completed by the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with a link to the questionnaire upon submission.
Permissions to reproduce previously published material
Authors must obtain prior permission to reproduce material published elsewhere (such as illustrations) from the copyright holder. The granting of permission should be acknowledged alongside the material (e.g., legend of a figure) in the submitted article. Authors are responsible for paying any fees to reproduce material.
Subject consent
Subjects have a right to privacy that should not be infringed without informed consent. Informed consent should be obtained from patients or other subjects of experiments that clearly grants permission for the publication of photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material. Identifying details (written or photographic) should be omitted if they are not essential, but subject data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve. For example, masking the eye region in photographs of subjects is inadequate protection of anonymity. When informed consent has been obtained, it should be indicated in the submitted article.
Ethics committee approval
All authors must sign a declaration that the research was conducted within the guidelines below and under the terms of all relevant local legislation. Please also look at the latest version of the Declaration of Helsinki (www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). The Editors reserve the right to judge the appropriateness of the use and treatment of humans or animals in experiments for publication in the journal.
Human experiments: All work must be conducted in accordance with the Declaration of Helsinki. Papers describing experimental work on human participants which carries a risk of harm must include (1) a statement that the experiments were conducted with the understanding and the consent of each participant, and (2) a statement that the responsible ethical committee has approved the experiments.
Animal experiments: In papers describing experiments on living animals, include (1) a full description of any anaesthetic and surgical procedure used, and (2) evidence that all possible steps were taken to avoid animals' suffering at each stage of the experiment. In experiments involving the use of muscle relaxants, describe the precautions taken to ensure adequate anaesthesia. Authors should follow current guidelines on the acquisition, care and use of laboratory animals such as the National Academy of Sciences, "Guide for the Care and Use of Laboratory Animals".
Experiments on isolated tissues: Indicate precisely how you obtained the donor tissue.
Clinical trials, data sharing and behavioural evaluations
Authors reporting results of randomized controlled trials should include with their submission a complete checklist from the CONSORT statement, see http://www.consort-statement.org. For behavioural and public health evaluations involving non-randomized designs, authors should include with their submission a complete checklist from the TREND statement, see http://www.cdc.gov/trendstatement/.
Registration of clinical trials: As a condition for publication of a clinical trial in AIDS, registration of the trial in a public registry is required. Registration of a trial must be at or before the enrolment of participants. We will use the definition adopted by the ICMJE of a clinical trial 'as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome'. Studies such as phase 1 trials will be exempt. The editors of AIDS also do not advocate one particular registry but require that the registry utilized meet the criteria set out in the statement of policy of the ICMJE.
Data sharing: Clinical trial papers must contain a data sharing statement on whether data are available or not as outlined in the ICMJE policy (www.icmje.org). A data sharing plan must be included in a trial's registration for those that begin enrolling participants on or after 1 January 2019. Authors of secondary analyses using shared data must reference the source of the data and attest their use was in accordance with any terms agreed.
Authors are encouraged to follow the Sex and Gender Equity in Research (SAGER) reporting guidelines where relevant. The guidelines, that includes an authors’ checklist for gender-sensitive reporting, are available through the EQUATOR website at http://www.equator-network.org/reporting-guidelines/sager-guidelines/.
Authorship
All authors must meet the criteria for authorship as established by the International Committee of Medical Journal Editors, that they believe that the paper represents honest work, and that they are able to verify the validity of the results reported.
The corresponding author should list the principal contributions made by each of the authors to the article in the Acknowledgements section of the submission. The journal discourages a long list of authors (greater than 25); persons listed must meet the criteria of authorship of the International Committee of Medical Journal Editors. Persons listed as authors should have substantially contributed to the study's conception, design, and performance.
In the case of a large study group involvement, please list the names of authors that meet the ICMJE criteria on the title page of the paper and include a study group name, if required, to encompass other author contributors. These other author contributors will be recognised as authors and the information submitted to indexers. The study group name on the title page should be marked with a superscript asterisk, with a footnote on the title page stating "*A list of other author contributors are listed in the Acknowledgment section." Clearly identify in the Acknowledgement section the list of those individuals who meet the author criteria after a superscript asterisk and study group name and the text "author contributors:". Please include the first name(s) and last name (underlined) for each person in this group for correct indexing as authors. Other study sites and participants should be identified and listed separately to this study group.
Authors who use AI tools in the writing of a manuscript, production of images or graphical elements of the paper, or in the collection and analysis of data, must be transparent in disclosing in the Materials and Methods (or similar section) of the paper how the AI tool was used and which tool was used. Authors are fully responsible for the content of their manuscript, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics.
Copyright assignment
Please note that copyright disclosure is required for the submission of all manuscripts. This is irrespective of whether an author chooses the Open Access option when an article is accepted for publication. This is included in the online author questionnaire.
Open access
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of submission. Please note that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.
The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Hybrid Open Access Journals page.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.
Creative Commons license
Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-Non Commercial No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes, nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here.
Read and Publish Agreements
Wolters Kluwer currently has read-and-publish agreements with institutional consortia listed here.
Corresponding authors who are affiliated with the participating institution and who qualify as eligible authors* can publish their eligible articles open access in the eligible LWW journals at no direct cost to them. Please see your institution’s individual policy for guidance on eligible article types and license choice. To qualify for the APC waiver, the corresponding author must provide their participating institution’s name and institutional email address in the journal’s submission system. On acceptance, the corresponding author will be asked to place an open access order in the publisher’s payment portal where they will be able to request the APC be funded in accordance with this agreement. A $0.00 APC will then be applied.
*Eligible authors: Corresponding authors who are teaching and research staff employed by or otherwise accredited to one of the participating institutions as well as students enrolled or accredited to one of the institutions and who want to publish open access articles.
Compliance with National Institutes of Health Accessibility Requirements
The National Institutes of Health (NIH) requires authors to submit the “post-print” (the final manuscript, in Word format, after peer-review and acceptance for publication but prior to the publisher’s copyediting, design, formatting, and other services) of research the NIH funds to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the NIH to PubMed Central.
FAQ for open access
https://www.wolterskluwer.com/en/solutions/lippincott-journals/lippincott-open-access/faq
PRESENTATION OF PAPERS
Title Page
The Title Page should carry the full title of the paper (not more than 120 characters) and a short title (not more than 40 characters) to be used as a 'running head' (and which should be so identified). Titles should not contain names of specific studies, a description of the procedures used, or the location of the study. The given or first name, middle initial and family name (surname) of each author should appear. The family name (surname) must appear in CAPITAL letters. If the work is to be attributed to a department or institution, its full name should be included. Total number of words used should be clearly stated on the Title Page. Any disclaimers should appear on the Title Page, as should the name and address (and email) of the author responsible for correspondence concerning the manuscript. Finally, the Title Page should include the sources of any support for the work in the form of grants, equipment, drugs, or any combination of these. Disclose funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Abstracts
The abstract should not exceed 250 words and should follow one
of the following two styles:
- Articles concerning original scientific research should include a structured abstract with the following headings and information:
- Articles containing original data concerning the course, cause, diagnosis, treatment, prevention or economic analysis of a clinical disorder or an intervention to improve the quality of health care should include a structured abstract with the following headings and information:
Objective(s): State the primary objective of the paper (if appropriate).
Design: State the principal reasoning for the procedures adopted.
Methods: State the procedures used.
Results: State the main results of the study. Numerical data should be kept to a minimum.
Conclusions: State the conclusions that can be drawn from the
data given.
Objective: State the main question or objective of the study and the major hypothesis tested, if any.
Design: Describe the design of the study indicating, as appropriate, use of randomisation, blinding, criterion standards for diagnostic tests, temporal direction (retrospective or prospective), etc.
Setting: Indicate the study setting, including the level of clinical care (for example, primary or tertiary: private practice or institutional).
Subjects, participants: State selection procedures, entry criteria and numbers of participants entering and finishing the study.
Intervention: Describe the essential features of any interventions including their method and duration of administration.
Main outcome measure(s): The primary study outcome measures should be indicated as planned before data collection began. If the hypothesis being reported was formulated during or after data collection, this fact should be clearly stated.
Results: Describe measurements that are not evident from the nature of the main results and indicate any blinding. Absolute values should be indicated when risk changes or effect sizes are given.
Conclusions: State only those conclusions of the study that are directly supported by data, along with their clinical application (avoiding over generalisation). Equal emphasis must be given to positive and negative findings of equal scientific merit.
Key Words
The abstract should be followed by a list of 5-7 keywords or short phrases
which will assist the cross-indexing of the article and which may be published.
The terms used should be from the Medical Subject Headings list of the US National Library of Medicine (http://www.nlm.nih.gov/mesh/meshhome.html).
Include terms from the AIDS classifications that appear on the Fast Track
submission form at the back of each journal issue, and on the submission
website at http://aids.edmgr.com/.
Text
Full papers of an experimental or observational nature may be divided into
sections headed Introduction, Methods (including ethical and statistical
information), Results, and Discussion (including a conclusion), although
reviews may require a different format.
Acknowledgements
The corresponding author should list the principal contributions made by each of the authors to the
article. Acknowledgements should be made only to those who have made a substantial
contribution to the study. Authors are responsible for obtaining written
permission from people acknowledged by name in case readers infer their
endorsement of data and conclusions. Sources of funding should be placed
in this section.
References
References should be numbered consecutively in the order in which they first
appear in the text. They should be assigned Arabic numerals, which should
be given in brackets, e.g. [17]. References should include the names of
all authors when six or fewer; when seven or more, list only the first six
names and add et al. References should also include full title
and source information. Journal names should be abbreviated as in the MEDLINE (http://www.nlm.nih.gov).
Articles in journals
Standard journal article:
-
Wood BR. Metabolic dysfunction associated steatotic liver disease in persons with HIV: understanding the serious implications and renaming of ‘fatty liver disease’. AIDS 2023; 37:2445-2446.
More than six authors:
- Perazzolo S, Stephen ZR, Eguchi M, Xu X, Delle Fratte R, Collier AC, et al. A novel formulation enabled transformation of 3-HIV drugs tenofovir–lamivudine–dolutegravir from short-acting to long-acting all-in-one injectable. AIDS 2023; 37:2131-2136.
Supplements:
-
Sanders EJ, Jaffe H, Musyoki H, Muraguri N, Graham SM. Kenyan MSM: no longer a hidden population. AIDS 2015; 29(Suppl 3):S195-S199.
Letter/Abstract/Conference Proceeding:
-
Álvarez H, Mariño A, García-Rodríguez JF, Vilas-Sueiro A, Valcarce N, Llibre JM. Immune reconstitution inflammatory syndrome in an HIV-infected patient using subcutaneous silicone fillers [Letter]. AIDS 2016; 30:2561-2563.
Dobra A, Bärnighausen T, Vandormael A, Tanser F. Space-time migration patterns and risk of HIV acquisition in rural South Africa [Abstract]. AIDS 2017; 31:137.
Bumpus N, Ma Q, Best B, Moore DJ, Ellis R, Crescini M, et al. Antiretroviral Drug Concentrations in Human Brain Tissue Are Similar to or Exceed Historical Concentrations in CSF. [Abstract 436] 22th Conference on Retroviruses and opportunistic infections (CROI) 23-26 February 2015
Books
Book:
-
Myers JW, Moorman JP, Salgado C. Gant'z Manual of Clinical Problems in Infectious Disease, 6E. Philadelphia: LWW; 2012.
Chapter in a book:
-
Parsons CH, Boger MS. Drug Interactions in Patients with HIV Infection. In: Gant'z Manual of Clinical Problems with Infectious Disease 6E. Myers R, Moorman JP, Salgado C (editors). Philadelphia: LWW; 2012. pp. 20-35.
Personal communications and unpublished work should not feature in the reference list but should appear in parentheses in the text. Unpublished work accepted for publication but not yet released should be included in the reference list with the words in press in parentheses beside the name of the journal concerned. References must be verified by the author(s) against the original documents.
Tables
Each table should be typed on a separate sheet in double spacing. Tables
should not be submitted as photographs. Each table should be assigned an
Arabic numeral, e.g. (Table 3) and a brief title. Vertical rules should
not be used. Place explanatory matter in footnotes, not in the heading.
Explain in footnotes all non-standard abbreviations that are used in each
table. Identify statistical measures of variations, such as standard deviation
and standard error of the mean.
Be sure that each table is cited in the text. If you use a table or data from another published or unpublished source, obtain permission and acknowledge the source fully.
Illustrations
References to figures and tables should be made in order of appearance in
the text and should be in Arabic numerals in parentheses, e.g. (Fig. 2).
If hard copies of figures are submitted they should have a label pasted
to the back bearing the figure number, the title of the paper, the author's
name and a mark indicating the top of the figure. Illustrations should not
be mounted. Half-tone illustrations should be presented as glossy prints
to a width of 82 mm; line illustrations should be presented as original
artwork or prints to a width of 82 mm or, when the illustration demands
it, to a width of 173 mm. Photomicrographs must have internal scale markers.
If photographs of people are used, their identities must be obscured or
the picture must be accompanied by written consent to use the photograph.
If a figure has been published before, the original source must be acknowledged
and written permission from the copyright holder for both print and electronic
formats should be submitted with the material. Permission is required regardless
of authorship or publisher, except for documents in the public domain. Figures
may be reduced, cropped or deleted at the discretion of the editor. Colour
illustrations are acceptable but authors will be expected to cover the extra
reproduction costs (for current charges, contact the publisher).
Digital Artwork
A) Creating Digital Artwork
-
Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42
-
Create, Scan and Save your artwork and compare your final figure to the Digital Artwork Guideline Checklist (below).
-
Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.
B) Digital Artwork Guideline Checklist
Here are the basics to have in place before submitting your digital artwork:
- Artwork should be saved as JPEG, TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High resolution PDF files are also acceptable.
- Crop out any white or black space surrounding the image.
- Please use either Ariel or Helvetica font size 7 for any text or labels within illustrations
- Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of at least 1200 dpi. If created in an MS Office program, send the native (DOC, PPT, XLS) file.
- Photographs, radiographs and other halftone images must be saved at a resolution of at least 300 dpi.
- Photographs and radiographs with text must be saved as postscript or at a resolution of at least 600 dpi.
- Each figure must be saved and submitted as a separate file. Figures should not be embedded in the manuscript text file.
Remember:
- Cite figures consecutively in your manuscript.
- Number figures in the figure legend in the order in which they are discussed.
- Upload figures consecutively to the Editorial Manager web site and enter figure numbers consecutively in the Description field when uploading the files.
- If you use an illustration from another published or unpublished source, obtain permission and acknowledge the source fully.
Legends for illustrations
Captions should be typed in double spacing, beginning on a separate sheet
of paper. Each one should have an Arabic numeral corresponding to the illustration
to which it refers. Internal scales should be explained and staining methods
for photomicrographs should be identified.
Units of measurement
Measurements of length, height, weight, and volume should be reported in
metric units (metre, kilogram, or litre) or their decimal multiples. Temperatures
should be given in degrees Celsius. Blood pressures should be given in millimetres
of mercury.
All haematologic and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Editors may request that alternative or non-SI units be added by the authors before publication.
Abbreviations and symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract.
The full term for which an abbreviation stands should precede its first
use in the text unless it is a standard unit of measurement.
Offprints
Offprints may be purchased using the appropriate form that will be made
available with proofs. Orders should be sent when the proofs are returned;
orders received after this time cannot be fulfilled.
Supplemental Digital Content (including Graphical and Video Abstracts)
Authors may submit SDC via Editorial Manager to LWW journals that enhance their article's text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by LWW staff, they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
Infographic (Graphical Abstracts)
Authors are encouraged to create and submit an infographic (graphical abstract) with their paper. This image will be published with the article on the Journal website. A graphical abstract aims to serve as a visual summary of the key findings of a paper for readers. A graphical abstract can be a powerful way of engaging with readers, and providing this in a format that can be used in Social Media, such as a jpeg, is required. Authors must ensure that they have permission or copyright to use any images including in the visual abstract.
Wolters Kluwer, in partnership with Editage, offers services to create such graphical abstracts. For more information, please visit Research Promotion Services and the “Infographics” section. Please note that the use of this or other services are at the author's own expense and risk, and independent from the editorial processes of this journal, and does not guarantee that an article will be accepted for publication.
Video Abstracts
Authors are encouraged to submit a Video Abstract to accompany their article. Guidelines for preparation of the Video Abstract, along with links to sample Video Abstracts, can be found here.
SDC Call-outs
Supplemental Digital Content must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as "Supplemental Digital Content," include the sequential list number, and provide a description of the supplemental content. All descriptive text should be included in the call-out as it will not appear elsewhere in the article.
Example:
We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.
List of Supplemental Digital Content
A listing of Supplemental Digital Content must be submitted at the end of the manuscript file. Include the SDC number and file type of the Supplemental Digital Content. This text will be removed by our production staff and not be published.
Example:
Supplemental Digital Content 1.wmv
SDC File Requirements
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
